GGrantIndex
← Leaderboards

Ann G Schwartz

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$30,622,299
Attributed
$40,625,620
Total exposure
15
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.9M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$47,362,692 · 17

By mechanism

R01$17,933,281 · 3
U01$14,156,439 · 1
P01$5,441,010 · 3
P20$4,472,994 · 6
N01$2,980,568 · 1
R33$1,539,904 · 1

Top collaborators

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsAfrican AmericanMalignant Neoplasm Of LungGeneticProgramsParticipantCancer Health DisparityRaceEnrollmentReportingDiagnosisCommunitiesCancer SurvivorCohortGrantEvaluationIncidenceLinkCancer RiskMetropolitanTumorPopulation BasedQuality Of LifeCessation Of Life

Grant awards (59)

Genetic Variation in Cancer Risk and Outcomes in African Americans$1,860,121
P01 · FY2025 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,065,093
U01 · FY2025 · CA · contact PI
I-REACH (Infrastructure for REsearch on Cancer and Aging)$759,485
R33 · FY2025 · AG
Core 1$654,206
P01 · FY2025 · CA · contact PI
Admin Core$144,664
P01 · FY2025 · CA · contact PI
Administrative Core$129,560
P20 · FY2025 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$102,988
U01 · FY2025 · CA · contact PI
Genetic Variation in Cancer Risk and Outcomes in African Americans$1,919,811
P01 · FY2024 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,016,242
U01 · FY2024 · CA · contact PI
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$780,419
R33 · FY2024 · AG
Core 1$706,228
P01 · FY2024 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$195,882
U01 · FY2024 · CA · contact PI
Admin Core$155,980
P01 · FY2024 · CA · contact PI
Administrative Core$107,484
P20 · FY2024 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,052,005
U01 · FY2023 · CA · contact PI
Reducing Cancer Health Disparities in Detroit$973,764
P20 · FY2023 · CA · contact PI
Project 1$287,916
P20 · FY2023 · CA · contact PI
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$216,418
R21 · FY2023 · AG
Characterizing the relationship between medical mistrust, health behaviors and neighborhood level factors in African American cancer survivors.$102,102
U01 · FY2023 · CA · contact PI
Administrative Core$52,765
P20 · FY2023 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,077,655
U01 · FY2022 · CA · contact PI
Reducing Cancer Health Disparities in Detroit$989,994
P20 · FY2022 · CA · contact PI
Project 1$517,215
P20 · FY2022 · CA · contact PI
I-REACH: Infrastructure for Research in Equity, Aging, Cancer and Health$258,418
R21 · FY2022 · AG
Administrative Core$51,417
P20 · FY2022 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,654,351
U01 · FY2021 · CA · contact PI
Reducing Cancer Health Disparities in Detroit$993,382
P20 · FY2021 · CA · contact PI
Project 1$314,071
P20 · FY2021 · CA · contact PI
Administrative Core$55,426
P20 · FY2021 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,971,519
U01 · FY2020 · CA · contact PI
The impact of the COVID-19 pandemic on African American cancer survivors and their caregivers$153,988
U01 · FY2020 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$2,102,386
U01 · FY2019 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,995,543
U01 · FY2018 · CA · contact PI
Detroit Research on Cancer Survivors (Detroit ROCS)$1,666,685
U01 · FY2017 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$909,096
R01 · FY2016 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$1,919,858
R01 · FY2015 · CA · contact PI
Profiling Genetic Alterations in NSCLC in African Americans$231,420
R21 · FY2015 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$1,866,387
R01 · FY2014 · CA · contact PI
Profiling Genetic Alterations in NSCLC in African Americans$132,240
R21 · FY2014 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$724,405
R01 · FY2013 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$1,738,264
R01 · FY2012 · CA · contact PI
Inflammation Pathways and COPD in the Development of Lung Cancer$1,568,379
R01 · FY2011 · CA · contact PI
Genetic Epidemiology of Lung Cancer$584,279
R01 · FY2009 · CA · contact PI
Genetic Epidemiology of Lung Cancer$276,140
R01 · FY2009 · CA · contact PI
Genetic Epidemiology of Lung Cancer$729,169
R01 · FY2008 · CA · contact PI
Genetic Epidemiology of Lung Cancer$727,821
R01 · FY2007 · CA · contact PI
Genetic Epidemiology of Lung Cancer$738,592
R01 · FY2006 · CA · contact PI
Adenocarinoma of the Lung in Women$632,943
R01 · FY2005 · CA
Genetic Epidemiology of Lung Cancer$621,844
R01 · FY2005 · CA
Adenocarinoma of the Lung in Women$614,505
R01 · FY2004 · CA
GENETIC EPIDEMIOLOGY OF LUNG CANCER$653,221
R01 · FY2003 · CA
Adenocarinoma of the Lung in Women$596,626
R01 · FY2003 · CA
GENETIC EPIDEMIOLOGY OF LUNG CANCER$639,888
R01 · FY2002 · CA
Adenocarinoma of the Lung in Women$589,718
R01 · FY2002 · CA
GENETIC EPIDEMIOLOGY OF LUNG CANCER$623,451
R01 · FY2001 · CA
Adenocarinoma of the Lung in Women$557,707
R01 · FY2001 · CA
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS--SEER$1,700,829
N01 · FY2000 · PC
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS--SEER$1,279,739
N01 · FY2000 · PC
GENETIC EPIDEMIOLOGY OF LUNG CANCER$620,988
R01 · FY2000 · CA